Zydus Wellness Ltd Q1 FY2025 Concall Summary

Source transcript PDF: https://www.stockscans.in/document/41jg3pys42wtg95qziax9eqs.pdf

Key Takeaways


Demand & Category Performance

Arora: "over any 3- to 4-year period of time, we do expect a consistent -- sorry, double-digit growth across the portfolio. Now if a bad season happens like last year, that can happen, but that doesn't put us out too substantially"

Margins & Cost Structure

Parikh: "This is an abnormally high number and we should not evaluate bridges."

Innovation & Portfolio Development


Strategy & Capital Allocation

Arora: "We've got a strategy consultant who can work co-create with us to build strength because we believe we are on the right path. We are focusing on the brand building, category building. But given the task we have... we are market leaders in 5 of our brands, which means that we are not just fighting for market share, but category building."

Guidance & Commitments

CommitmentSpecificsTimeline
Revenue growthDouble-digit growth trajectoryFY25 and going forward
EBITDA margin17-18%Over the next couple of years (2-3 years)
Sweetener growthDouble-digit growth trajectoryOver the next year
Capex₹30-35 crore, maintenance and some capacity expansionFY25
DebtRemain debt-freeOngoing, unless acquisition opportunity arises
Tax cash outflowZero cash tax paymentFY25 and FY26
New product launches4 more innovationsComing quarters
Margin seasonalityQ2 and Q3 EBITDA/operating margins "much lower" than Q1/Q4Structural, every year

Key Metrics

MetricQ1 FY25
Consolidated net sales₹839.1 cr, +20% YoY, of which 17.1% is volume growth
Personal Care segment growth41.8% YoY
Food & Nutrition segment growth15% YoY
Gross margin improvement314 bps YoY and 114 bps QoQ
EBITDA₹155.3 cr, +33.3% YoY
EBITDA margin~18% for Q1
Net profit after tax₹147.7 cr, +33.8% YoY
Adjusted PAT growth39.6% YoY, excluding exceptional items and one-time deferred tax effects from comparable quarter of previous year
Advertisement expenses growth19.1% YoY
Other expenses growth27.7% YoY; excluding strategy consultant cost, grew 6%
Employee cost increase25% YoY, abnormally high due to ~1.5% occupancy rise and one-off PF transition to government PF
Strategy consultant cost~₹20-21 cr, ~2.5% of quarter sales (per an analyst's math)
Capex planned for FY25₹30-35 cr, maintenance capex
E-commerce share of business~9.5% of overall
Glucon-D value market share59.7% in glucose powder category at MAT level
Everyuth scrub market share46.2% in facial scrub category, +373 bps YoY at MAT level
Everyuth peel-off market share78.2% in peel-off category, +200 bps YoY at MAT level
Nycil market share34.9% in prickly heat powder category at MAT level
Sugar Free market share95.9% in sugar substitute category at MAT level
Complan market share4.3% in nutrition drink category at MT level
Glucon-D brand penetration increase160 bps vs last year, per MAT-May 24 Kantar Panel
Complan brand penetration increase23 bps vs last year, per MAT-May 24 Kantar Panel
Rural contribution to consumption20-30% across most brands; Glucon-D and Nycil >30%, Complan, Sugar Free, Everyuth 18-25%, Nutralite much lower
Distribution outlets~0.29-0.3 cr outlets, split 50-50 urban and rural
Q2 and Q3 revenue contributionTypically ~1/3 of annual revenue
Medium-term EBITDA margin target17-18%, expected over the next couple of years